Monday, July 18, 2016

Ardelyx Picks Up $110M In PIPE From Venture Investors

Fremont-based biopharmaceuticals developer Ardelyx said Friday that it has received $110M in a private placement, which came from both new and existing investors, including New Enterprise Assocaites (NEA), plus Australia's Future Fund, Quadrille Capital, EcoR1 Capital, RA Capital Management, First Manhattan Co., Rock Springs Capital, Cormorant Asset Management, Perceptive Advisors, Deerfield and DAFNA Capital Management. The company said the funds goes towards Phase 3 development efforts. Ardelyx is listed on the NASDAQ as ARDX, and led by Mike Raab. More information »